JP4252899B2 - 多小胞状エマルジョンを含む局所適用組成物及びその製造方法 - Google Patents
多小胞状エマルジョンを含む局所適用組成物及びその製造方法 Download PDFInfo
- Publication number
- JP4252899B2 JP4252899B2 JP2003524360A JP2003524360A JP4252899B2 JP 4252899 B2 JP4252899 B2 JP 4252899B2 JP 2003524360 A JP2003524360 A JP 2003524360A JP 2003524360 A JP2003524360 A JP 2003524360A JP 4252899 B2 JP4252899 B2 JP 4252899B2
- Authority
- JP
- Japan
- Prior art keywords
- composition
- emulsion
- active substance
- agents
- oil
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/002—Aftershave preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/14—Liposomes; Vesicles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/41—Amines
- A61K8/416—Quaternary ammonium compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/68—Sphingolipids, e.g. ceramides, cerebrosides, gangliosides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A61P23/02—Local anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/14—Ectoparasiticides, e.g. scabicides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/04—Preparations for care of the skin for chemically tanning the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/10—Washing or bathing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Birds (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Anesthesiology (AREA)
- Dispersion Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Tropical Medicine & Parasitology (AREA)
- Rheumatology (AREA)
- Biotechnology (AREA)
- Toxicology (AREA)
- Pain & Pain Management (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Colloid Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Description
Claims (16)
- 多小胞状エマルジョンを含む局所適用組成物であって、組成物の総質量当たり0.1〜30質量%の乳化剤としてのベヘントリモニウムメトスルフェート、オイル相、水相、及び小胞内に捕捉されている薬学的又は薬理学的活性物質を含み、多小胞状エマルジョンが、2相水中油形エマルジョンで、オイル及び水相の同心球状物又はシェルの一連の多層薄板状を有し、薬科学的又は薬理学的活性物質を長期間持続放出する多小胞状エマルジョンを含む局所適用組成物。
- ベヘントリモニウムメトスルフェートを、脂肪族アルコール補助乳化剤と併用する請求項1記載の組成物。
- 脂肪族アルコール補助乳化剤がセテアリルアルコールである請求項2記載の組成物。
- 補助乳化剤の量が、ベヘントリモニウムメトスルフェートの量の1.5〜4倍である請求項3記載の組成物。
- 薬学的又は薬理学的活性物質がオイル小胞に存在する請求項1記載の組成物。
- 薬学的又は薬理学的活性物質が水小胞に存在する請求項1記載の局所適用組成物。
- 粉末状賦形剤を含む請求項1記載の組成物。
- 粉末状賦形剤が、タルク及びコーンスターチで成る群から選ばれるものである請求項7記載の組成物。
- 粉末状賦形剤がタルクである請求項8記載の組成物。
- 微量成分を含む請求項1記載の組成物。
- 微量成分が、保存料、皮膚軟化剤、保湿剤、エマルジョン安定剤、防水剤、皮膚保護剤、コンディショナー及びフレグランスで成る群から選ばれるものである請求項10記載の組成物。
- 組成物が、ローション、クリーム、スプレー可能なクリーム、パウダー製剤から成る群から選ばれる適用形状である請求項1記載の組成物。
- 半固体クリームである請求項1記載の組成物。
- 薬学的又は薬理学的活性物質が、ニキビ治療剤、鎮痛剤、麻酔薬、坐剤、抗ヒスタミン剤、抗炎症剤、抗生物質、抗真菌剤、抗ウイルス剤、抗菌剤、抗疥癬剤、殺シラミ薬、抗腫瘍剤、制汗剤、かゆみ止め、アンチセプティックス、抗脂漏薬、火傷治療剤、焼灼薬、脱色剤、おむつかぶれ治療薬、酵素、育毛剤、ケラトリティック、口唇潰瘍薬、口唇ヘルペス薬、歯科用作用物質、唾液作用物質、光線感作性薬、ステロイド、日焼け止め剤、いぼ作用物質、外傷治療製品、メトロニダゾール、及びビタミンAから成る群から選択されたものである請求項1記載の組成物。
- 2相水中油形エマルジョンで、オイル及び水相の同心球状物又はシェルの一連の多層薄板状を有し、薬科学的又は薬理学的活性物質を長期間持続放出する多小胞状エマルジョンを含む局所適用組成物を製法する方法であって、前記活性物質を、この活性物質に応じてオイル相又は水相である相溶性がある基剤と混合し、その後、活性物質及び基剤を、組成物全体の0.1〜30質量%のベヘントリモニウムメトスルフェート乳化剤と混合して、活性物質を持続放出できる多小胞状エマルジョンとすることを特徴とする2相水中油形エマルジョンで、オイル及び水相の同心球状物又はシェルの一連の多層薄板状を有し、薬科学的又は薬理学的活性物質を長期間持続放出する多小胞状エマルジョンを含む局所適用組成物を製法する方法。
- ベヘントリモニウムメトスルフェート乳化剤の量が、組成物全体の0.5〜5質量%である請求項15記載の方法。
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/944,760 US6709663B2 (en) | 2001-08-31 | 2001-08-31 | Multivesicular emulsion drug delivery systems |
PCT/US2002/020896 WO2003020037A1 (en) | 2001-08-31 | 2002-07-02 | Multivesicular emulsion topical delivery systems |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2005501877A JP2005501877A (ja) | 2005-01-20 |
JP4252899B2 true JP4252899B2 (ja) | 2009-04-08 |
Family
ID=25482022
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2003524360A Expired - Lifetime JP4252899B2 (ja) | 2001-08-31 | 2002-07-02 | 多小胞状エマルジョンを含む局所適用組成物及びその製造方法 |
Country Status (16)
Country | Link |
---|---|
US (1) | US6709663B2 (ja) |
EP (1) | EP1420645B1 (ja) |
JP (1) | JP4252899B2 (ja) |
KR (1) | KR100615116B1 (ja) |
CN (1) | CN100404019C (ja) |
AT (1) | ATE447392T1 (ja) |
AU (1) | AU2002320238B2 (ja) |
BR (1) | BRPI0212116B8 (ja) |
CA (1) | CA2457852C (ja) |
DE (1) | DE60234260D1 (ja) |
DK (1) | DK1420645T3 (ja) |
ES (1) | ES2336083T3 (ja) |
HK (1) | HK1065921A1 (ja) |
MX (1) | MXPA04001885A (ja) |
PT (1) | PT1420645E (ja) |
WO (1) | WO2003020037A1 (ja) |
Families Citing this family (61)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8512718B2 (en) | 2000-07-03 | 2013-08-20 | Foamix Ltd. | Pharmaceutical composition for topical application |
US6932976B2 (en) * | 2002-08-08 | 2005-08-23 | Kimberly-Clark Worldwide, Inc. | Enzyme blocking skin protectant cream |
IL152486A0 (en) | 2002-10-25 | 2003-05-29 | Meir Eini | Alcohol-free cosmetic and pharmaceutical foam carrier |
US7704518B2 (en) | 2003-08-04 | 2010-04-27 | Foamix, Ltd. | Foamable vehicle and pharmaceutical compositions thereof |
US9211259B2 (en) | 2002-11-29 | 2015-12-15 | Foamix Pharmaceuticals Ltd. | Antibiotic kit and composition and uses thereof |
EP1556009B2 (en) | 2002-10-25 | 2021-07-21 | Foamix Pharmaceuticals Ltd. | Cosmetic and pharmaceutical foam |
US20080138296A1 (en) | 2002-10-25 | 2008-06-12 | Foamix Ltd. | Foam prepared from nanoemulsions and uses |
US9668972B2 (en) | 2002-10-25 | 2017-06-06 | Foamix Pharmaceuticals Ltd. | Nonsteroidal immunomodulating kit and composition and uses thereof |
US8486376B2 (en) | 2002-10-25 | 2013-07-16 | Foamix Ltd. | Moisturizing foam containing lanolin |
US8900554B2 (en) | 2002-10-25 | 2014-12-02 | Foamix Pharmaceuticals Ltd. | Foamable composition and uses thereof |
US7820145B2 (en) | 2003-08-04 | 2010-10-26 | Foamix Ltd. | Oleaginous pharmaceutical and cosmetic foam |
US9265725B2 (en) | 2002-10-25 | 2016-02-23 | Foamix Pharmaceuticals Ltd. | Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof |
US10117812B2 (en) | 2002-10-25 | 2018-11-06 | Foamix Pharmaceuticals Ltd. | Foamable composition combining a polar solvent and a hydrophobic carrier |
US8119150B2 (en) | 2002-10-25 | 2012-02-21 | Foamix Ltd. | Non-flammable insecticide composition and uses thereof |
US7700076B2 (en) | 2002-10-25 | 2010-04-20 | Foamix, Ltd. | Penetrating pharmaceutical foam |
US8119109B2 (en) | 2002-10-25 | 2012-02-21 | Foamix Ltd. | Foamable compositions, kits and methods for hyperhidrosis |
US7575739B2 (en) * | 2003-04-28 | 2009-08-18 | Foamix Ltd. | Foamable iodine composition |
US7556819B1 (en) * | 2003-07-25 | 2009-07-07 | Opi Products, Inc. | Skin composition |
US20080069779A1 (en) * | 2003-08-04 | 2008-03-20 | Foamix Ltd. | Foamable vehicle and vitamin and flavonoid pharmaceutical compositions thereof |
US8486374B2 (en) | 2003-08-04 | 2013-07-16 | Foamix Ltd. | Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses |
US8795693B2 (en) | 2003-08-04 | 2014-08-05 | Foamix Ltd. | Compositions with modulating agents |
US20050095283A1 (en) * | 2003-09-16 | 2005-05-05 | Aphios Corporation | Compositions and methods for topically treating diseases |
WO2005053638A2 (en) * | 2003-11-29 | 2005-06-16 | Passion For Life Healthcare Limited | Composition and delivery system |
DE102004013633A1 (de) * | 2004-03-19 | 2005-10-06 | Beiersdorf Ag | Tapioka in kosmetischen Zubereitungen |
US7754775B2 (en) * | 2004-04-23 | 2010-07-13 | Mercier Michel F | Multi-lamellar liquid crystal emulsion system |
JP2005310310A (ja) * | 2004-04-23 | 2005-11-04 | Sanyo Electric Co Ltd | トラッキングバランス調整装置 |
EP1799179A2 (en) * | 2004-10-13 | 2007-06-27 | The Procter and Gamble Company | Hair conditioning composition comprising an alkyl diquaternized ammonium salt cationic surfactant |
US20060239943A1 (en) * | 2005-04-21 | 2006-10-26 | Tomasi Nestor S | Formula and method for providing protection from dermatitis, sunlight and/or insects |
US8277788B2 (en) * | 2005-08-03 | 2012-10-02 | Conopco, Inc. | Quick dispersing hair conditioning composition |
GB0609797D0 (en) * | 2006-05-17 | 2006-06-28 | Univ Aston | Adhesive solution for application to the skin |
US8715700B2 (en) * | 2006-07-21 | 2014-05-06 | Dow Pharmaceutical Sciences, Inc. | Alpha hydroxy acid sustained release formulation |
US20080260655A1 (en) | 2006-11-14 | 2008-10-23 | Dov Tamarkin | Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses |
US8636982B2 (en) | 2007-08-07 | 2014-01-28 | Foamix Ltd. | Wax foamable vehicle and pharmaceutical compositions thereof |
US9439857B2 (en) | 2007-11-30 | 2016-09-13 | Foamix Pharmaceuticals Ltd. | Foam containing benzoyl peroxide |
WO2010041141A2 (en) | 2008-10-07 | 2010-04-15 | Foamix Ltd. | Oil-based foamable carriers and formulations |
WO2009090495A2 (en) | 2007-12-07 | 2009-07-23 | Foamix Ltd. | Oil and liquid silicone foamable carriers and formulations |
EP2242476A2 (en) | 2008-01-14 | 2010-10-27 | Foamix Ltd. | Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses |
EP2095808A1 (en) * | 2008-02-26 | 2009-09-02 | Johnson & Johnson Consumer France SAS | Self tanning compositions containing oils |
NZ590950A (en) * | 2008-07-18 | 2012-12-21 | Biomod Concepts Inc | Articles of manufacture releasing an active ingredient |
FR2940067B1 (fr) * | 2008-12-19 | 2011-02-25 | Oreal | Composition oxydante pour le traitement des fibres keratiniques comprenant un polymere cationique, un amide gras et un agent-oxygene |
EP2395965B1 (de) * | 2009-02-12 | 2018-04-04 | Evonik Schlüchtern GmbH | Kationisches trägersystem aus positiv geladenen lipidvesikeln |
US20120087872A1 (en) | 2009-04-28 | 2012-04-12 | Foamix Ltd. | Foamable Vehicles and Pharmaceutical Compositions Comprising Aprotic Polar Solvents and Uses Thereof |
US20100303910A1 (en) * | 2009-05-29 | 2010-12-02 | Marilyne Candolives | Topical skin care compositions |
US20100305064A1 (en) * | 2009-05-29 | 2010-12-02 | Walsh Star M | Topical skin care compositions |
WO2011013009A2 (en) | 2009-07-29 | 2011-02-03 | Foamix Ltd. | Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses |
WO2011013008A2 (en) | 2009-07-29 | 2011-02-03 | Foamix Ltd. | Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses |
US9849142B2 (en) | 2009-10-02 | 2017-12-26 | Foamix Pharmaceuticals Ltd. | Methods for accelerated return of skin integrity and for the treatment of impetigo |
US10029013B2 (en) | 2009-10-02 | 2018-07-24 | Foamix Pharmaceuticals Ltd. | Surfactant-free, water-free formable composition and breakable foams and their uses |
US8174881B2 (en) | 2009-11-24 | 2012-05-08 | Micron Technology, Inc. | Techniques for reducing disturbance in a semiconductor device |
DE102010030001A1 (de) * | 2010-06-11 | 2010-12-09 | Rovi Cosmetics International Gmbh | Kosmetische Zusammensetzung zum Färben der Haare mit einem direktziehenden Haarfarbstoff und mit einem Trägersystem aus Lipidvesikeln |
US10610486B2 (en) | 2010-10-28 | 2020-04-07 | Pacira Pharmaceuticals, Inc. | Sustained release formulation of a non-steroidal anti-inflammatory drug |
US8809307B2 (en) | 2010-11-22 | 2014-08-19 | Dow Pharmaceutical Sciences, Inc. | Pharmaceutical formulations containing corticosteroids for topical administration |
US8481480B1 (en) * | 2012-04-30 | 2013-07-09 | Uyen T. Lam | Anti-adherent formulation including a quaternary ammonium compound and a fatty alcohol |
CN106488698A (zh) * | 2014-05-26 | 2017-03-08 | 加利福尼亚大学董事会 | 有机修剪伤口组合物 |
KR20170093190A (ko) | 2014-12-03 | 2017-08-14 | 마리 케이 인코포레이티드 | 화장품 조성물 |
HUE050603T2 (hu) | 2015-06-18 | 2020-12-28 | Bausch Health Ireland Ltd | Egy kortikoszteroidot és egy retinoidot tartalmazó topikális készítmények psoriasis kezelésére |
MX2020012139A (es) | 2016-09-08 | 2021-01-29 | Vyne Pharmaceuticals Inc | Composiciones y metodos para tratar rosacea y acne. |
WO2018094253A1 (en) | 2016-11-18 | 2018-05-24 | Pacira Pharmaceuticals, Inc. | Zinc meloxicam complex microparticle multivesicular liposome formulations and processes for making the same |
US10813852B2 (en) | 2017-11-16 | 2020-10-27 | L'oreal | Bi-phase micellar liquid product comprising ceramides |
US10653656B2 (en) | 2018-04-05 | 2020-05-19 | Bausch Health Ireland Limited | Topical pharmaceutical compositions for treating skin conditions |
US20220347062A1 (en) * | 2021-04-29 | 2022-11-03 | L'oreal | Sunscreen spray |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4911928A (en) | 1987-03-13 | 1990-03-27 | Micro-Pak, Inc. | Paucilamellar lipid vesicles |
US5165994A (en) | 1990-06-05 | 1992-11-24 | University Of Delaware | Spontaneous equilbrium surfactant vesicles |
US5229104A (en) * | 1991-04-29 | 1993-07-20 | Richardson-Vicks Inc. | Artificial tanning compositions containing positively charged paucilamellar vesicles |
US5597555A (en) * | 1992-04-02 | 1997-01-28 | Croda, Inc. | Fatty alkoxylate esters of aliphatic and aromatic dicarboxylic acids |
US5766627A (en) | 1993-11-16 | 1998-06-16 | Depotech | Multivescular liposomes with controlled release of encapsulated biologically active substances |
EP0788305B1 (en) | 1994-03-28 | 2004-11-03 | The Trustees of Columbia University in the City of New York | Composition for inactivating irritants in fluids |
US5601811A (en) | 1994-08-01 | 1997-02-11 | Croda, Inc. | Substantive water-soluble cationic UV-absorbing compounds |
US5520908A (en) | 1994-10-14 | 1996-05-28 | Minnetonka Research Institute, Inc. | Hair, skin and nail treatment composition and method |
US5804203A (en) * | 1994-12-21 | 1998-09-08 | Cosmederm Technologies | Topical product formulations containing strontium for reducing skin irritation |
US5679327A (en) | 1995-08-25 | 1997-10-21 | Johnson Products Co., Inc. | Hair straightening emulsion |
US5804293A (en) * | 1995-12-08 | 1998-09-08 | Ppg Industries, Inc. | Coating composition for recording paper |
US6071535A (en) | 1996-01-31 | 2000-06-06 | Collaborative Laboratories, Inc. | Lipid vesicles formed with alkylammonium fatty acid salts |
US5869071A (en) | 1996-11-07 | 1999-02-09 | B & G Labs, Inc. | One-step skin cleaning composition and skin treatment method for incontinent dermatitis |
US5843193A (en) | 1997-03-18 | 1998-12-01 | Revlon Consumer Products Corporation | Hair dye compositions and process |
FR2761912B1 (fr) * | 1997-04-14 | 1999-07-02 | Capsulis | Procede destine a faire adherer un produit sur une surface |
US5871763A (en) | 1997-04-24 | 1999-02-16 | Fort James Corporation | Substrate treated with lotion |
US6322778B1 (en) * | 1998-02-10 | 2001-11-27 | Johnson & Johnson Consumer Companies, Inc. | Hair conditioning compositions comprising a quaternary ammonium compound |
US6010690A (en) | 1998-03-05 | 2000-01-04 | Bristol-Myers Squibb Company | Alkaline hair conditioning compositions containing cationic guar |
US6024951A (en) | 1998-03-13 | 2000-02-15 | S. C. Johnson & Son, Inc. | Soap-free shave lotion that increases surface adherence and related methods |
WO2000065911A1 (en) * | 1999-04-30 | 2000-11-09 | Sintal International, Inc. | Anti-bacterial composition and use thereof for skin care and fabric treatment |
-
2001
- 2001-08-31 US US09/944,760 patent/US6709663B2/en not_active Expired - Lifetime
-
2002
- 2002-07-02 AT AT02749743T patent/ATE447392T1/de active
- 2002-07-02 MX MXPA04001885A patent/MXPA04001885A/es active IP Right Grant
- 2002-07-02 WO PCT/US2002/020896 patent/WO2003020037A1/en active IP Right Grant
- 2002-07-02 DE DE60234260T patent/DE60234260D1/de not_active Expired - Lifetime
- 2002-07-02 AU AU2002320238A patent/AU2002320238B2/en not_active Expired
- 2002-07-02 ES ES02749743T patent/ES2336083T3/es not_active Expired - Lifetime
- 2002-07-02 EP EP02749743A patent/EP1420645B1/en not_active Expired - Lifetime
- 2002-07-02 JP JP2003524360A patent/JP4252899B2/ja not_active Expired - Lifetime
- 2002-07-02 CA CA002457852A patent/CA2457852C/en not_active Expired - Lifetime
- 2002-07-02 KR KR1020047003004A patent/KR100615116B1/ko active IP Right Grant
- 2002-07-02 CN CNB028217748A patent/CN100404019C/zh not_active Expired - Lifetime
- 2002-07-02 PT PT02749743T patent/PT1420645E/pt unknown
- 2002-07-02 BR BRPI0212116A patent/BRPI0212116B8/pt not_active IP Right Cessation
- 2002-07-02 DK DK02749743.7T patent/DK1420645T3/da active
-
2004
- 2004-11-09 HK HK04108795.6A patent/HK1065921A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
HK1065921A1 (en) | 2005-03-11 |
EP1420645B1 (en) | 2009-11-04 |
BRPI0212116B8 (pt) | 2021-05-25 |
BRPI0212116B1 (pt) | 2016-01-19 |
BR0212116A (pt) | 2004-07-20 |
CN1578626A (zh) | 2005-02-09 |
DK1420645T3 (da) | 2010-03-15 |
DE60234260D1 (de) | 2009-12-17 |
ES2336083T3 (es) | 2010-04-08 |
ATE447392T1 (de) | 2009-11-15 |
CN100404019C (zh) | 2008-07-23 |
EP1420645A4 (en) | 2006-09-06 |
CA2457852A1 (en) | 2003-03-13 |
US20030049281A1 (en) | 2003-03-13 |
JP2005501877A (ja) | 2005-01-20 |
PT1420645E (pt) | 2010-02-04 |
WO2003020037A1 (en) | 2003-03-13 |
KR100615116B1 (ko) | 2006-08-22 |
US6709663B2 (en) | 2004-03-23 |
MXPA04001885A (es) | 2005-04-19 |
KR20040044512A (ko) | 2004-05-28 |
AU2002320238B2 (en) | 2005-02-17 |
EP1420645A1 (en) | 2004-05-26 |
CA2457852C (en) | 2006-06-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4252899B2 (ja) | 多小胞状エマルジョンを含む局所適用組成物及びその製造方法 | |
AU2002320238A1 (en) | Multivesicular emulsion topical delivery systems | |
US8449923B2 (en) | Methods for inhibiting sensory nerves by topically administering strontium-containing compositions to keratinized skin | |
US5804203A (en) | Topical product formulations containing strontium for reducing skin irritation | |
JP4115391B2 (ja) | 薬学的に上品な局所軟膏に使用するための脂質中に分散した硬化ヒマシ油 | |
JPH09157172A (ja) | 皮膚外用剤及び湿疹薬 | |
JPH03178916A (ja) | 皮膚外用剤 | |
JPH11139951A (ja) | 化粧料 | |
US20060148907A1 (en) | Topical antinflammatory preparations of y-terpinene | |
JPH082772B2 (ja) | 皮脂分泌促進剤 | |
JP3193617B2 (ja) | 清涼感付与剤および人体用組成物 | |
JP2787451B2 (ja) | 養毛料 | |
JPH10194914A (ja) | 皮膚外用剤 | |
JPH0352806A (ja) | 養毛料 | |
JPH11269023A (ja) | 外用組成物 | |
JPS62155204A (ja) | 皮膚外用剤 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20071204 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20080304 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20080311 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20080325 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20080513 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20080806 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20080806 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20080930 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20081010 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20081017 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20081031 |
|
A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20081202 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20090106 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20090122 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 4252899 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120130 Year of fee payment: 3 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130130 Year of fee payment: 4 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130130 Year of fee payment: 4 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
EXPY | Cancellation because of completion of term |